Pentagon Reinstates Controversial Testosterone Testing for Military Personnel

Pentagon reinstates testosterone testing for service members over 30, sparking medical concerns. PolicyWire investigates.

Editorial Desk

September 18, 2026 One Min Read

POLICY WIRE — Washington, United States — The U.S. Department of Defense has resumed a mandatory testosterone screening program for service members aged 30 and older, despite widespread criticism from medical professionals who call the initiative unnecessary and potentially risky.

The decision comes after a brief pause in early September, during which the Pentagon reviewed its guidance on hormonal testing. The policy, first introduced by Defense Secretary Pete Hegseth in July, includes screening for both men and women, with women undergoing questionnaires to assess hormonal imbalances before treatment options are considered.

📄 POLICY WIRE WHITEPAPER PUBLISHED: PAKISTAN’S NATIONAL SECURITY POLICY PRIORITIES

👉 READ BY CLICKING HERE

A Pentagon spokesperson confirmed the reinstatement, stating that the updated guidance aims to standardize care for male testosterone deficiency. However, experts have raised concerns about the potential side effects of testosterone therapy, including infertility and other long-term health risks if not properly managed.

Reporting by Policy-Wire (PW)

Author

Editorial Desk

Policy Wire is your go-to editorial hub for insightful perspectives and informed analysis on pressing policy issues, both regionally and globally. Over the years, Policy Wire has collaborated with leading international news agencies—including AFP, AP, Reuters, and others—to provide fact-based reporting and nuanced commentary. With a commitment to clarity and credibility, we aim to bridge the gap between complex policy debates and public understanding, ensuring that our readers stay informed on the issues shaping the world today.